sizofiran has been researched along with ovalbumin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoshi, T; Ishii, KJ; Kobiyama, K; Mochizuki, S; Morishita, H; Sakurai, K | 1 |
| Ki, CS; Kim, H; Lee, S | 1 |
2 other study(ies) available for sizofiran and ovalbumin
| Article | Year |
|---|---|
Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
Topics: Adjuvants, Immunologic; Animals; Antigen-Presenting Cells; Cancer Vaccines; Cells, Cultured; Immunization; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Mice, Inbred C57BL; Neoplasms; Oligodeoxyribonucleotides; Ovalbumin; Peptide Fragments; Sizofiran; Spleen; T-Lymphocytes, Cytotoxic; Tissue Distribution; Tumor Burden | 2015 |
Modular formation of hyaluronic acid/β-glucan hybrid nanogels for topical dermal delivery targeting skin dendritic cells.
Topics: Administration, Cutaneous; Animals; beta-Glucans; Cell Line; Dendritic Cells; Drug Carriers; Hyaluronic Acid; Immunologic Factors; Immunomodulation; Methacrylates; Mice; Nanogels; Ovalbumin; Proof of Concept Study; Sizofiran; Skin Absorption; Swine | 2021 |